Sale!

Cresp 40 mcg PFS Injection

Original price was: $ 39.85.Current price is: $ 17.40.

-56%

Cresp 40mcg Injection (Darbepoetin Alfa) is used to treat anemia associated with chronic kidney disease and chemotherapy, helping to increase red blood cell production.

2 reviews
👀 37 people are currently viewing this product.
💬 20 people have inquired via WhatsApp.

Interested in Product?

Submit Product Enquiry


🌍 Worldwide Shipping


🇺🇸 USA
🇬🇧 UK
🇪🇺 Europe
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇦🇺 Australia
🇨🇳 China
🇷🇺 Russia


🔒 Guaranteed Safe Checkout


Visa
MasterCard
PayPal
Crypto
Secure payments • Encrypted checkout • Buyer protection

Cresp 40mcg Injection contains Darbepoetin Alfa, a synthetic form of the hormone erythropoietin that stimulates the production of red blood cells. It is primarily used to treat anemia caused by chronic kidney disease (CKD) or chemotherapy in cancer patients. By promoting red blood cell production, Cresp helps improve oxygen levels in the blood, reducing the symptoms of anemia like fatigue and weakness.

This medication is administered under the supervision of a healthcare professional to ensure the correct dosage and monitor its effects.

Key Features:

  • Contains Darbepoetin Alfa to effectively manage anemia
  • Commonly used in patients with chronic kidney disease and those undergoing chemotherapy
  • Increases red blood cell production, improving energy levels and reducing fatigue
  • Administered under medical supervision for accurate dosing and monitoring

Additional information

Weight 0.50 kg
Dimensions 10 × 10 × 10 cm
Composition

Darbepoetin

2 reviews for Cresp 40 mcg PFS Injection

5.0
Based on 2 reviews
5 star
100
100%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
1-2 of 2 reviews
  1. quick and great service. Flawless order-payment- and delivery.

    (0) (0)
  2. I m from Kerala I have inj purchased in milanmedicals.com Good service and fast delivery. Product rate is very low

    (0) (0)
Add a review
You must be logged in to post a review Log In

Q & A

Ask a question
There are no questions yet